Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes.
Rocca B, Santilli F, Pitocco D, Mucci L, Petrucci G, Vitacolonna E, Lattanzio S, Mattoscio D, Zaccardi F, Liani R, Vazzana N, Del Ponte A, Ferrante E, Martini F, Cardillo C, Morosetti R, Mirabella M, Ghirlanda G, Davì G, Patrono C. Rocca B, et al. Among authors: mattoscio d. J Thromb Haemost. 2012 Jul;10(7):1220-30. doi: 10.1111/j.1538-7836.2012.04723.x. J Thromb Haemost. 2012. PMID: 22471290 Free article. Clinical Trial.
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients.
Santilli F, Romano M, Recchiuti A, Dragani A, Falco A, Lessiani G, Fioritoni F, Lattanzio S, Mattoscio D, De Cristofaro R, Rocca B, Davì G. Santilli F, et al. Among authors: mattoscio d. Blood. 2008 Aug 15;112(4):1085-90. doi: 10.1182/blood-2007-11-123091. Epub 2008 Jun 9. Blood. 2008. PMID: 18541722 Free article.
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy.
Dragani A, Pascale S, Recchiuti A, Mattoscio D, Lattanzio S, Petrucci G, Mucci L, Ferrante E, Habib A, Ranelletti FO, Ciabattoni G, Davì G, Patrono C, Rocca B. Dragani A, et al. Among authors: mattoscio d. Blood. 2010 Feb 4;115(5):1054-61. doi: 10.1182/blood-2009-08-236679. Epub 2009 Nov 3. Blood. 2010. PMID: 19887674 Free article. Clinical Trial.
Clinical and laboratory phenotype associated with the aspirin-like defect.
Dragani A, Brancati F, Pascale S, Mattoscio D, Rocca B. Dragani A, et al. Among authors: mattoscio d. Br J Haematol. 2010 Feb;148(4):661-3; author reply 663-4. doi: 10.1111/j.1365-2141.2009.07950.x. Epub 2009 Oct 7. Br J Haematol. 2010. PMID: 19814736 Free article. No abstract available.
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response.
Mattoscio D, Evangelista V, De Cristofaro R, Recchiuti A, Pandolfi A, Di Silvestre S, Manarini S, Martelli N, Rocca B, Petrucci G, Angelini DF, Battistini L, Robuffo I, Pensabene T, Pieroni L, Furnari ML, Pardo F, Quattrucci S, Lancellotti S, Davì G, Romano M. Mattoscio D, et al. FASEB J. 2010 Oct;24(10):3970-80. doi: 10.1096/fj.10-159921. Epub 2010 Jun 8. FASEB J. 2010. PMID: 20530751
31 results